Andrew Gengos - Net Worth and Insider Trading
Andrew Gengos Net Worth
The estimated net worth of Andrew Gengos is at least $200,255 dollars as of 2025-07-24. Andrew Gengos is the CFO of Terns Pharmaceuticals Inc and owns about 25,000 shares of Terns Pharmaceuticals Inc (TERN) stock worth over $152,250. Andrew Gengos is also the CFO and Chief Business Officer of Athira Pharma Inc and owns about 97,532 shares of Athira Pharma Inc (ATHA) stock worth over $48,005. Details can be seen in Andrew Gengos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Gengos has not made any transactions after 2025-06-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Andrew Gengos
Andrew Gengos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Gengos owns 4 companies in total, including Synlogic Inc (SYBX) , EOM Pharmaceutical Holdings Inc (IMUC) , and Cyteir Therapeutics Inc (CYTT) among others .
Click here to see the complete history of Andrew Gengos’s form 4 insider trades.
Insider Ownership Summary of Andrew Gengos
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SYBX | Synlogic Inc | 2017-10-09 | See Remarks |
IMUC | EOM Pharmaceutical Holdings Inc | 2016-12-31 | director |
CYTT | Cyteir Therapeutics Inc | 2021-06-17 | Chief Business Officer |
![]() | ![]() | 2024-09-05 | See Below |
Andrew Gengos Latest Holdings Summary
Andrew Gengos currently owns a total of 2 stocks. Among these stocks, Andrew Gengos owns 25,000 shares of Terns Pharmaceuticals Inc (TERN) as of June 27, 2025, with a value of $152,250 and a weighting of 76.03%. Andrew Gengos also owns 97,532 shares of Athira Pharma Inc (ATHA) as of September 5, 2024, with a value of $48,005 and a weighting of 23.97%.
Latest Holdings of Andrew Gengos
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TERN | Terns Pharmaceuticals Inc | 2025-06-27 | 25,000 | 6.09 | 152,250 |
ATHA | Athira Pharma Inc | 2024-09-05 | 97,532 | 0.49 | 48,005 |
Holding Weightings of Andrew Gengos
Andrew Gengos Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Gengos has made a total of 2 transactions in Terns Pharmaceuticals Inc (TERN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Terns Pharmaceuticals Inc is the acquisition of 10,000 shares on June 27, 2025, which cost Andrew Gengos around $39,300.
According to the SEC Form 4 filings, Andrew Gengos has made a total of 5 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in Athira Pharma Inc is the sale of 1,272 shares on September 5, 2024, which brought Andrew Gengos around $725.
Insider Trading History of Andrew Gengos
- 1
Andrew Gengos Trading Performance
GuruFocus tracks the stock performance after each of Andrew Gengos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Gengos is -32.75%. GuruFocus also compares Andrew Gengos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Gengos within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Gengos's insider trading performs compared to the benchmark.
Performance of Andrew Gengos
Andrew Gengos Ownership Network
Ownership Network List of Andrew Gengos
Ownership Network Relation of Andrew Gengos

Andrew Gengos Owned Company Details
What does Synlogic Inc do?
Who are the key executives at Synlogic Inc?
Andrew Gengos is the See Remarks of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Head of Finance Mary Beth Dooley , and 10 percent owner Funicular Funds, Lp .
Synlogic Inc (SYBX) Insider Trades Summary
Over the past 18 months, Andrew Gengos made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 2,518 shares made by Mary Beth Dooley , and a net sale of 372 shares made by Antoine Awad .
In summary, during the past 3 months, insiders sold 0 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,890 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,890 shares.
Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synlogic Inc Insider Transactions
Andrew Gengos Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Gengos. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Andrew Gengos's mailing address is: Woodland Hills Ca 91367.